Animal & Plant Derived Vaccines


Track 17: Animal & Plant Derived Vaccines



It has been about 30 years since the first plant engineering technology was established. Although the concept of plant-based pharmaceuticals or vaccines motivates us to develop practicable commercial products using plant engineering, there are some difficulties in reaching the final goal: to manufacture an approved product. At present, the only plant-made vaccine approved by the United States Department of Agriculture is a Newcastle disease vaccine for poultry that is produced in suspension-cultured tobacco cells. The progress toward commercialization of plant-based vaccines takes much effort and time, but several candidate vaccines for use in humans and animals are in clinical trials. This review discusses plant engineering technologies and regulations relevant to the development of plant-based vaccines and provides an overview of human and animal vaccines currently under clinical trials.


    Related Conference of Animal & Plant Derived Vaccines

    May 25-26, 2022

    International Conference on Vaccine & Vaccine Research

    Auckland, Newzealand
    June 23-24, 2022

    International Congress on Vaccines and Virology

    Zurich, Switzerland
    June 23-24, 2022

    Global Summit on Vaccines & Emerging Diseases

    Zurich, Switzerland
    June 23-24, 2022

    35th World Congress on Vaccines and Immunization

    Bangkok, Thailand
    June 27-28, 2022

    Global Summit on Hepatitis Vaccine

    Zurich, Switzerland
    September 05-06, 2022

    42nd Global Summit and Expo on Vaccines & Immunology

    Paris, France
    October 05-06, 2022

    34th International Conference on Vaccines and Immunization

    Zurich, Switzerland
    November 04-05, 2022

    34th Annual Congress on Vaccine and Clinical Trials

    Toronto, Canada
    November 17-18, 2022

    2nd Global Summit on Vaccines and Immunology

    Berlin, Germany

    Animal & Plant Derived Vaccines Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in